Global Cancer Test Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 3668

Cancer is the second-leading cause of death and disability in the world, only behind heart disease. More people die from cancer around the world than AIDS, Tuberculosis and Malaria combined every year.
According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Therefore, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians.
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.
In 2018, the global Cancer Test market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cancer Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Test development in United States, Europe and China.

The key players covered in this study
Abbott
Radient Pharmaceuticals
BD Diagnostics
Beckman Coulter
BioCurex
bioMerieux
Cepheid
CytoCore
DiagnoCure
Gen-Probe
Genomic Health
QIAGEN Marseille (Earlier Ipsogen)
Myriad Genetics
Panacea Pharmaceuticals
Qiagen
Siemens Heathcare Diagnostics
Roche
Ventana Medical Systems
Trovagene
Vermillion

Market segment by Type, the product can be split into
Laboratory Tests
Genetic Tests
Imaging
Endoscopy

Market segment by Application, split into
Bladder Cancer Test
Breast Cancer Test
Cervical Cancer Test
Colorectal (Colon) Cancer Test
Ovarian Cancer Test
Prostate Cancer Test
Liver Cancer Test
Flow Cytometry
Other Organ Specific Cancer Test

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cancer Test status, future forecast, growth opportunity, key market and key players.
To present the Cancer Test development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Test are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Test Market Size Growth Rate by Type (2014-2025)
1.4.2 Laboratory Tests
1.4.3 Genetic Tests
1.4.4 Imaging
1.4.5 Endoscopy
1.5 Market by Application
1.5.1 Global Cancer Test Market Share by Application (2014-2025)
1.5.2 Bladder Cancer Test
1.5.3 Breast Cancer Test
1.5.4 Cervical Cancer Test
1.5.5 Colorectal (Colon) Cancer Test
1.5.6 Ovarian Cancer Test
1.5.7 Prostate Cancer Test
1.5.8 Liver Cancer Test
1.5.9 Flow Cytometry
1.5.10 Other Organ Specific Cancer Test
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cancer Test Market Size
2.2 Cancer Test Growth Trends by Regions
2.2.1 Cancer Test Market Size by Regions (2014-2025)
2.2.2 Cancer Test Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cancer Test Market Size by Manufacturers
3.1.1 Global Cancer Test Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Test Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Test Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Test Key Players Head office and Area Served
3.3 Key Players Cancer Test Product/Solution/Service
3.4 Date of Enter into Cancer Test Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cancer Test Market Size by Type (2014-2019)
4.2 Global Cancer Test Market Size by Application (2014-2019)

5 United States
5.1 United States Cancer Test Market Size (2014-2019)
5.2 Cancer Test Key Players in United States
5.3 United States Cancer Test Market Size by Type
5.4 United States Cancer Test Market Size by Application

6 Europe
6.1 Europe Cancer Test Market Size (2014-2019)
6.2 Cancer Test Key Players in Europe
6.3 Europe Cancer Test Market Size by Type
6.4 Europe Cancer Test Market Size by Application

7 China
7.1 China Cancer Test Market Size (2014-2019)
7.2 Cancer Test Key Players in China
7.3 China Cancer Test Market Size by Type
7.4 China Cancer Test Market Size by Application

8 Japan
8.1 Japan Cancer Test Market Size (2014-2019)
8.2 Cancer Test Key Players in Japan
8.3 Japan Cancer Test Market Size by Type
8.4 Japan Cancer Test Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cancer Test Market Size (2014-2019)
9.2 Cancer Test Key Players in Southeast Asia
9.3 Southeast Asia Cancer Test Market Size by Type
9.4 Southeast Asia Cancer Test Market Size by Application

10 India
10.1 India Cancer Test Market Size (2014-2019)
10.2 Cancer Test Key Players in India
10.3 India Cancer Test Market Size by Type
10.4 India Cancer Test Market Size by Application

11 Central & South America
11.1 Central & South America Cancer Test Market Size (2014-2019)
11.2 Cancer Test Key Players in Central & South America
11.3 Central & South America Cancer Test Market Size by Type
11.4 Central & South America Cancer Test Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Test Introduction
12.1.4 Abbott Revenue in Cancer Test Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 Radient Pharmaceuticals
12.2.1 Radient Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Test Introduction
12.2.4 Radient Pharmaceuticals Revenue in Cancer Test Business (2014-2019)
12.2.5 Radient Pharmaceuticals Recent Development
12.3 BD Diagnostics
12.3.1 BD Diagnostics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Test Introduction
12.3.4 BD Diagnostics Revenue in Cancer Test Business (2014-2019)
12.3.5 BD Diagnostics Recent Development
12.4 Beckman Coulter
12.4.1 Beckman Coulter Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Test Introduction
12.4.4 Beckman Coulter Revenue in Cancer Test Business (2014-2019)
12.4.5 Beckman Coulter Recent Development
12.5 BioCurex
12.5.1 BioCurex Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Test Introduction
12.5.4 BioCurex Revenue in Cancer Test Business (2014-2019)
12.5.5 BioCurex Recent Development
12.6 bioMerieux
12.6.1 bioMerieux Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Test Introduction
12.6.4 bioMerieux Revenue in Cancer Test Business (2014-2019)
12.6.5 bioMerieux Recent Development
12.7 Cepheid
12.7.1 Cepheid Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Test Introduction
12.7.4 Cepheid Revenue in Cancer Test Business (2014-2019)
12.7.5 Cepheid Recent Development
12.8 CytoCore
12.8.1 CytoCore Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Test Introduction
12.8.4 CytoCore Revenue in Cancer Test Business (2014-2019)
12.8.5 CytoCore Recent Development
12.9 DiagnoCure
12.9.1 DiagnoCure Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Test Introduction
12.9.4 DiagnoCure Revenue in Cancer Test Business (2014-2019)
12.9.5 DiagnoCure Recent Development
12.10 Gen-Probe
12.10.1 Gen-Probe Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Test Introduction
12.10.4 Gen-Probe Revenue in Cancer Test Business (2014-2019)
12.10.5 Gen-Probe Recent Development
12.11 Genomic Health
12.12 QIAGEN Marseille (Earlier Ipsogen)
12.13 Myriad Genetics
12.14 Panacea Pharmaceuticals
12.15 Qiagen
12.16 Siemens Heathcare Diagnostics
12.17 Roche
12.18 Ventana Medical Systems
12.19 Trovagene
12.20 Vermillion

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details